BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33378802)

  • 1. [A comparative study of breast cancer mass screening and opportunistic screening in Chinese women].
    Shen SJ; Xu YL; Zhou YD; Ren GS; Jiang J; Jiang HC; Zhang J; Li B; Jin F; Li YP; Xie FM; Shi Y; Wang ZD; Sun M; Yuan SH; Yu JJ; Chen Y; Sun Q
    Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):109-115. PubMed ID: 33378802
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors for breast cancer in women undergoing mammography.
    Reuter KL; Baker SP; Krolikowski FJ
    AJR Am J Roentgenol; 1992 Feb; 158(2):273-8. PubMed ID: 1729780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Screening of colorectal cancer in Kunming urban residents from 2014 to 2017].
    Zhou H; Zhang X; Shen ZH; Chen XB; Zhao GQ; Lin YP; Huang YC; Zhang Q; Ma J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Nov; 22(11):1058-1063. PubMed ID: 31770837
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cost-effectiveness analysis of two breast cancer screening modalities in Shanghai, China].
    Mo M; Zheng Y; Liu G; Fang H; Zhang X; Zhai L; Chen Y; Lyu L; Zhu J; Luo J; Zhang L; Cao Z; Xu W; Shao Z
    Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):944-51. PubMed ID: 26887627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunistic breast cancer screening in Hong Kong; a revisit of the Kwong Wah Hospital experience.
    Lui CY; Lam HS; Chan LK; Tam KF; Chan CM; Leung TY; Mak KL
    Hong Kong Med J; 2007 Apr; 13(2):106-13. PubMed ID: 17406037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological characteristics and long-term prognosis of screening detected non-palpable breast cancer by ultrasound in hospital-based Chinese population (2001-2014).
    Pan B; Yao R; Zhu QL; Wang CJ; You SS; Zhang J; Xu QQ; Cai F; Shi J; Zhou YD; Mao F; Lin Y; Guan JH; Shen SJ; Liang ZY; Jiang YX; Sun Q
    Oncotarget; 2016 Nov; 7(47):76840-76851. PubMed ID: 27689334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of screening mammography among women with and without a first-degree relative with breast cancer.
    Kerlikowske K; Carney PA; Geller B; Mandelson MT; Taplin SH; Malvin K; Ernster V; Urban N; Cutter G; Rosenberg R; Ballard-Barbash R
    Ann Intern Med; 2000 Dec; 133(11):855-63. PubMed ID: 11103055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Breast cancer screening in urban Beijing, 2014-2019].
    Yang L; Zhang X; Liu S; Li HC; Zhang Q; Wang N; Ji JF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Sep; 54(9):974-980. PubMed ID: 32907288
    [No Abstract]   [Full Text] [Related]  

  • 9. Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk.
    Lee JM; Arao RF; Sprague BL; Kerlikowske K; Lehman CD; Smith RA; Henderson LM; Rauscher GH; Miglioretti DL
    JAMA Intern Med; 2019 May; 179(5):658-667. PubMed ID: 30882843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
    Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
    JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunistic mammography screening provides effective detection rates in a limited resource healthcare system.
    Teh YC; Tan GH; Taib NA; Rahmat K; Westerhout CJ; Fadzli F; See MH; Jamaris S; Yip CH
    BMC Cancer; 2015 May; 15():405. PubMed ID: 25972043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.
    Saadatmand S; Geuzinge HA; Rutgers EJT; Mann RM; de Roy van Zuidewijn DBW; Zonderland HM; Tollenaar RAEM; Lobbes MBI; Ausems MGEM; van 't Riet M; Hooning MJ; Mares-Engelberts I; Luiten EJT; Heijnsdijk EAM; Verhoef C; Karssemeijer N; Oosterwijk JC; Obdeijn IM; de Koning HJ; Tilanus-Linthorst MMA;
    Lancet Oncol; 2019 Aug; 20(8):1136-1147. PubMed ID: 31221620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis for the breast cancer screening among urban population in Hebei province, 2018-2019].
    He YT; Liu YY; Gao W; Hu JJ; Ma XY; Xia CJ; Chen SH; Wang J; Liang D; Shi J; Shan BE
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Apr; 55(4):535-538. PubMed ID: 33858068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound as the Primary Screening Test for Breast Cancer: Analysis From ACRIN 6666.
    Berg WA; Bandos AI; Mendelson EB; Lehrer D; Jong RA; Pisano ED
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26712110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful first round results of a Turkish breast cancer screening program with mammography in Bahcesehir, Istanbul.
    Kayhan A; Gurdal SO; Ozaydin N; Cabioglu N; Ozturk E; Ozcinar B; Aribal E; Ozmen V
    Asian Pac J Cancer Prev; 2014; 15(4):1693-7. PubMed ID: 24641392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of detection matters: Differences in screen-detected versus symptomatic breast cancers.
    Starikov A; Askin G; Blackburn A; Lu CM; Reznik E; Kim J; Bose A; Cheng E; Dodelzon K; Arleo EK
    Clin Imaging; 2021 Dec; 80():11-15. PubMed ID: 34218078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer screening and early diagnosis in China: a systematic review and meta-analysis on 10.72 million women.
    Li M; Wang H; Qu N; Piao H; Zhu B
    BMC Womens Health; 2024 Feb; 24(1):97. PubMed ID: 38321439
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.